MINNEAPOLIS, March 18, 2025 (GLOBE NEWSWIRE) -- Minnesota-based global NGO MATTER announced today that its MATTER 360 ...

Lipozem Beneficial Contribution in Human Body! Lipozem is an excellent product that has received a lot of positive reviews.

TrainHealth’s new medical device addresses a critical need in neurological clinics and hospitals and allows them to optimize 3 to 5 times the cost-efficiency of their therapies through its use. As ...

QUEBEC CITY, March 18, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D Canada is calling on the Quebec government to adopt the 2022 INESSS recommendation to eliminate current age restrictions on public ...

Manufacturing progress supports timelines toward filing of Emergency Use Authorization application by BARDA.

Cytrellis is commercializing in Canada immediately and has partnered with a leading local distributor to make ellacor available in Saudi Arabia. These two markets add to Cytrellis’ international ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that the Company will ...

Namodenoson, has been also granted Orphan Drug Designation by the FDA for pancreatic cancer. The designation as an orphan drug will provide, among others, potential for market exclusivity for seven ...

Amid the ongoing national challenge of health care access, Sutter Health is making significant strides to expand care to more patients when and where they need it. Plans are underway to open more than ...

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces the acquisition of the license for the ...